Kirin Holdings Kabushiki Kaisha

Kenta Jonai

Daisuke Fujiwara

Tetsu Sugimura

Toshihide Kurihara

Yuji Morita

This invention provides an IFN inducer comprising, as an active ingredient, lactic acid bacteria and capable of inducing IFN production, an immunopotentiating agent or prophylactic agent against virus infection comprising such inducer, and a food or drink product comprising such IFN inducer and having IFN-inducing activity, immunopotentiating activity, or prophylactic activity against virus infection. The agent for inducing IFN production comprises, as active ingredients, lactic acid bacteria that can activate plasmacytoid dendritic cells (pDCs) and promote IFN production, such asNBRC100934,subsp.JCM16167,subsp.NBRC100676,subsp.JCM1180,subsp.JCM11040,subsp.NBRC12007,subsp.NRIC1150,subsp.JCM5805,subsp.JCM20101,NBRC12455,NRIC1540,JCM5886, orTA-45.

Agent for inducing interferon production containing lactic acid bacteria

An object of the present invention is to provide a composition for preventing visual dysfunction caused by exposure to light, such as so-called blue light. The present invention provides a composition comprising a lactic acid bacterium as an active ingredient for use in suppressing or improving conditions caused by retinal inflammation resulting from light damage. Eye discomfort is an exemplary condition caused by retinal inflammation resulting from light damage.

Growing community of inventors

Kanagawa, Japan

Kenta Jonai